Skip to content
Vivo logo
← All articles

NMN vs NR: Differences, Evidence and How They Relate to NAD+

NMN vs NR: Differences, Evidence and How They Relate to NAD+

Abstract pathway linking NR, NMN and NAD+

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are two forms of vitamin B3 that the body can convert into NAD+. They differ in chemical structure and in the steps they take to become NAD+, but in the one large head-to-head human trial available, both raised blood NAD+ by a similar amount. Neither has shown consistent anti-aging or functional benefits in people. Neither one is NAD+ itself, which is a separate molecule and a separate question.

This guide compares NMN, NR and NAD+ on structure, evidence, safety, U.S. regulatory status and practical use, so the choice is based on what the research supports rather than on marketing.

VivoExplore Provider-Supervised NAD+ CareVivo offers provider-supervised NAD+ treatments with personalized treatment selection and precision-compounded therapies from licensed U.S. pharmacies.Explore NAD+ options

TL;DR

  • NR and NMN are closely related precursors. NMN is NR plus a phosphate group, and both feed the same salvage pathway that makes NAD+.
  • Both raise blood NAD+. In a 2026 randomized trial, 1,000 mg a day of either one for 14 days roughly doubled circulating NAD+ in healthy adults.
  • Higher NAD+ has not been shown to mean better health. Human trials on metabolism, vascular function and physical performance have been mixed or null.
  • NMN is not NAD+. A precursor is a raw material the body converts. NAD+ is the finished coenzyme, and prescription compounded forms are a different product category.
  • Which is “better” has no settled answer. Tolerability, cost, product quality and a clinician’s input matter more than small differences in absorption.

Table of Contents

What NMN and NR are

Both compounds are vitamin B3 derivatives that serve as NAD+ precursors in the human salvage pathway. NR is a pyridine nucleoside, and NMN is a nucleotide formed by adding a phosphate group to NR. That single phosphate group is the chemical difference.

The pathway runs in a specific order. NR kinases convert NR to NMN, and NMN adenylyltransferases then convert NMN to NAD+. NR therefore has one more step to complete than NMN does, though both end up in the same place.

NR to NMN to NAD+ conversion pathway

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell. It takes part in energy metabolism and in the activity of enzymes involved in DNA repair and cellular signaling. Levels are reported to decline with age, and that decline is the reason precursors became popular.

NAD+, NMN and NR: three different things

A common search is whether NMN is the same as NAD+. It is not. NMN is a precursor that the body converts into NAD+ through the salvage pathway, and NR is another precursor that can be converted to NMN and then to NAD+. Nicotinamide, a third vitamin B3 form, also feeds the same pathway.

The practical consequence is that taking a precursor is an indirect strategy. The body decides how much to convert, where, and how quickly. Taking NAD+ itself, for example as a compounded prescription nasal spray or injection, is a different route of administration with its own questions about dosing and supervision.

NMN vs NR compared

Dimension NR (nicotinamide riboside) NMN (nicotinamide mononucleotide) NAD+
What it is Pyridine nucleoside, vitamin B3 form Nucleotide: NR plus a phosphate group The coenzyme itself
Role Precursor Precursor End product
Path to NAD+ NR to NMN to NAD+ NMN to NAD+ None needed
Typical form Oral capsule or powder Oral capsule or powder Prescription spray, injection or cream (compounded)
Raised blood NAD+ in humans Yes, about 2-fold in a 2026 trial at 1,000 mg for 14 days Yes, about 2-fold in the same trial Depends on route, dose and product
Proven anti-aging benefit in humans No No No
Supervision Non-prescription supplement Non-prescription supplement Prescription, provider-supervised

How the evidence compares

Raising NAD+ levels

The most direct comparison is the 2026 Christen et al. study. In a randomized, placebo-controlled trial, 14 days of 1,000 mg of NR or 1,000 mg of NMN increased circulating NAD+ by approximately 2-fold versus placebo in healthy adults. The authors also reported increases in gut-derived metabolites, which suggests the supplements affect the gut as well as the blood.

That gut finding matters for interpretation. Nestlé Research proposes that the effect of orally ingested precursors is mediated substantially by gut microbiota, which convert them into nicotinic acid, rather than by direct uptake of the intact precursor. If that holds, the structural arguments about NR crossing membranes more directly than NMN matter less than they appear to in marketing.

Some sources describe NR as having a biochemical edge, for example by entering cells directly through nucleoside transporters while NMN must first be converted. Those arguments come mostly from cell and animal work and from small studies. The larger human trial did not show a meaningful difference in the blood NAD+ increase.

Health outcomes

Raising a blood marker is not the same as improving health. A review of dietary NAD±boosting compounds concluded that human studies have shown heterogeneous and often null results for outcomes such as metabolism, vascular function and physical performance, and that larger studies with meaningful endpoints are needed.

A 2026 systematic review covering January 2010 to October 2025 reached a similar position: human evidence shows biochemical activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive. The same review notes that promising rodent results have not yet translated into consistent, clinically meaningful human outcomes.

Another review in Science Advances goes further, observing that human NR supplementation has shown few clinically relevant effects and that the literature tends to overstate how strong the reported effects are. A fair reading is that both precursors are measurable, plausible and unproven for longevity.

For readers considering NAD+ for energy, the related question is whether any NAD-based approach produces functional gains. Our review of the energy literature is in NAD for energy: 23 studies, no consistent functional gains. Readers weighing over-the-counter options for fatigue can also look at supplements that can help improve energy, which covers how supplements fit alongside the basics.

Safety and tolerability

In human studies, NMN and NR supplementation were reported as generally well tolerated, with NR studied for up to 20 weeks. That is short-term data. Long-term safety at high doses is not established for either compound.

In the 2026 Christen trial, three adverse events had a probable relation to the product: abdominal pain in a placebo participant, low blood pressure in an NR participant and headache in an NMN participant. The small number and mixed distribution mean no clear pattern can be drawn.

Taking NR and NMN together

The research does not identify a trial of combined NR and NMN, so there is no evidence that stacking improves results. Because both feed the same pathway, taking both mainly adds cost and dose without a demonstrated benefit. A licensed provider or pharmacist should review any combination, particularly for people who take blood pressure medication, are pregnant or nursing, have a chronic condition, or are scheduled for surgery.

Reading product claims

Supplement marketing frequently outpaces evidence. In 2020 the FDA and FTC issued a warning letter to one company whose NMN and NAD+ products were marketed as preventing or treating COVID-19, making them unapproved new drugs. A product that promises to treat or cure a disease is a warning sign, whatever the ingredient.

U.S. availability and regulatory status

NR and NMN have had different regulatory paths in the United States.

Lawful as a supplement does not mean evaluated for effectiveness. Dietary supplements are not reviewed by the FDA for safety and efficacy before they are sold, and quality varies between manufacturers. Look for independent third-party testing and a clear statement of the amount of NR or NMN per serving.

How to choose between NMN and NR

Because the evidence does not separate the two, the decision comes down to practical factors. A reasonable checklist:

  1. Goal. If the goal is simply to raise measured NAD+, either has done so in trials. If the goal is a health outcome, neither has proven it.
  2. Evidence depth. NR has the longer human research record, including studies up to 20 weeks. NMN human data is newer and shorter.
  3. Product quality. Prefer third-party tested products with the dose listed per serving and no disease claims.
  4. Medications and conditions. Discuss with a licensed provider before starting, especially with low blood pressure, cardiovascular disease, cancer history or pregnancy.
  5. Cost against expected benefit. Daily doses in trials were around 1,000 mg, which is often higher than a typical label serving. Compare the price of the trial-level dose, not the price per bottle.
  6. Tracking. If you follow wearables or lab work, define a baseline and a time frame before starting, and treat the results as individual data rather than proof.

When people look at prescription NAD+ instead

Some adults who have tried NMN or NR move to a prescription NAD+ route, or compare it with paying for IV drip or NAD+ lounge visits. The reasons vary: wanting a defined, provider-supervised product, a different route of administration, or a reviewed treatment plan rather than an over-the-counter bottle.

It is worth being precise about what that means. Prescription NAD+ is also unproven for anti-aging in humans, and it is not a more potent version of a supplement by default. What changes is the structure around it: a licensed provider reviews a health history, decides whether a therapy is appropriate and monitors the patient over time, and a licensed U.S. 503A compounding pharmacy prepares the product against a prescription. Readers who want detail on dose labeling can read about NAD+ nasal spray dosing and why it depends on your label, or on the injectable form. The topic of emerging peptides is covered in U.S. adults and peptides for longevity.

When people look at prescription NAD+ instead

Vivo NAD+ options

Vivo offers provider-supervised NAD+ therapy through telehealth, with compounded products prepared by licensed U.S. pharmacies and delivered to the patient. The NAD+ nasal spray is $129 per month, and the NAD+ face cream is also $129 per month. Treatment is prescribed only after a provider reviews the patient’s intake and approves it, and patient data is handled under HIPAA-compliant practices. For a summary of what is known about topical use, see what the evidence supports for NAD+ cream.

Perspective: why supervision matters more than the precursor

We see the NMN versus NR question often, and the honest answer is that the research does not crown a winner. Both raise blood NAD+, and neither has shown reliable improvements in the outcomes people care about, such as energy, metabolism or physical performance.

That is why our approach starts with the person rather than the molecule. A provider reviews history, goals and current medications, and a treatment is selected only if it is appropriate. We then rely on licensed U.S. compounding pharmacies and ongoing provider oversight, so the patient is not guessing about dose, source or interaction.

For adults who want NAD+ itself, a supervised prescription pathway offers defined products, a clear route of administration and a clinician to ask. We make no promise of anti-aging results, because the evidence does not support one, and we think a clear statement of that is part of responsible care.

Jack

FAQ

Is NMN the same as NAD+?

No. NMN is a precursor that the body converts to NAD+ through the salvage pathway. NAD+ is the coenzyme itself, and precursors differ from it in how they are absorbed and converted.

Which is better, NMN or NR?

The evidence does not show a clear winner. In a 2026 randomized trial, both roughly doubled blood NAD+ at 1,000 mg a day for 14 days, and neither has proven anti-aging benefits. NR has a longer human research record, while NMN has been lawful as a dietary supplement again since the FDA’s 2025 decision.

Is it safe to take NR and NMN together?

No trial in the research tests the combination, so its safety and benefit are unestablished. Each is generally well tolerated alone in short-term human studies. Anyone on medication or with a health condition should ask a licensed provider or pharmacist before combining them.

Why did Amazon stop selling NMN?

After the FDA took the position at the end of 2022 that NMN could not be sold as a dietary supplement, major retailers removed it. The agency reversed that position in September 2025, though retailer policies are set by the retailers themselves.

Sources